Judge Rejects Theranos Investors' Bid To Pause Settlements
A proposed class of Theranos Inc. investors is moving forward with a securities fraud suit against the health technology startup after losing a bid to pause the company's settlements with Walgreen...To view the full article, register now.
Already a subscriber? Click here to view full article